Ludwig Ruder

11 Oct 2022 Analysis Madura Jayatunga, Lotte Bruens, Ludwig Ruder, Ulrik Schulze, Christoph Meier Executive Summary AI is beginning to transform biologics discovery. The power of algorithms used in biologics discovery has increased over the last decade, and today between 50 and 60 AI-enabled biologics are in different stages of discovery, preclinical and clinical development.

Artificial intelligence (AI) offers the potential to transform drug discovery. Over the last few years, AI-enabled drug discovery has grown substantially through technological progress, such as the use of neural networks to design molecules and the application of knowledge graphs to understand target biology.

Abstract The brainstem is a key centre in the control of body movements. Although the precise nature of brainstem cell types and circuits that are central to full-body locomotion are becoming known1,2,3,4,5, efforts to understand the neuronal underpinnings of skilled forelimb movements have focused predominantly on supra-brainstem centres and the spinal cord6,7,8,9,10,11,12.